Showing 981 - 1,000 results of 105,173 for search '(( 2 mg decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.60s Refine Results
  1. 981

    A brief course of RAP treatment decreases markers of proliferation and increases markers of differentiation. by Karin M. Hardiman (555189)

    Published 2014
    “…<p><i>CDX2P-CreER<sup>T2</sup> Apc<sup>fl/fl</sup></i> mice were injected with TAM and monitored until polyposis was seen endoscopically, then the mice were treated with vehicle or RAP at 3 mg/kg concentration for periods of one, three, or five days (N = 5 per timepoint). …”
  2. 982
  3. 983
  4. 984
  5. 985
  6. 986

    Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

    Published 2013
    “…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”
  7. 987
  8. 988
  9. 989
  10. 990

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”
  11. 991

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”
  12. 992
  13. 993
  14. 994
  15. 995
  16. 996
  17. 997
  18. 998
  19. 999
  20. 1000